Note 37 InvestorsObserver puts shares of Repligen Corporation (RGEN) near the middle of the medical devices and supplies industry. In addition to scoring more than 43% of stocks in the medical devices and supplies industry, RGEN’s overall rating of 37 means the stock scores better than 37% of all stocks.
What do these notes mean?
Finding the best stocks to invest in can be difficult. There are thousands of options and it can be confusing to know what really constitutes great value. InvestorsObserver lets you choose from eight unique metrics to display the top industries and top performing stocks within that industry. A score of 37 would be higher than 37% of all actions. These rankings allow you to easily compare stocks and see what the strengths and weaknesses of a given company are. This allows you to find the stocks with the best short-term and long-term growth prospects in seconds. The combined score incorporates technical and fundamental analysis to provide a comprehensive view of a stock’s performance. Investors who then want to focus on analyst rankings or valuations can view separate scores for each section.
What’s going on with Repligen Corporation shares today?
Repligen Corporation (RGEN) stock is trading at $157.15 at 1:20 p.m. on Monday, May 2, down -$0.09, or -0.06% from the previous closing price of 157, $24. Volume today is less active than usual. So far, 236,577 shares have been traded with an average volume of 599,388 shares. The stock has traded between $152.01 and $161.08 so far today. Click here for the full Repligen Corporation stock report.
Stay in the know
Subscribe to our daily morning update newsletter and never miss market news, moves and more.